Depression in children and adolescents.

Area of Science:

• Child and Adolescent Psychiatry
• Developmental Psychology
• Neuroscience

Background:

• Pediatric depression prevalence is up to 8.9%, with distinct symptoms from adult depression.
• Both neurobiological and psychosocial factors contribute to the development of depression in youth.
• Childhood depression symptoms differ from adult presentations, necessitating specialized understanding.

Purpose of the Study:

• To review the current understanding of depression in children and adolescents.
• To highlight treatment challenges and evidence-based approaches for pediatric depression.
• To inform clinical practice regarding the management of youth depression.

Main Methods:

• A selective literature review was conducted.
• The review focused on epidemiological data, symptom presentation, and treatment efficacy.
• Evidence-based findings on pediatric depression were synthesized.

Main Results:

• High spontaneous remission rates (33%) in childhood contrast with persistent depression into adulthood (80%).
• Limited evidence-based treatments exist for pediatric depression compared to adults.
• Fluoxetine is the only licensed medication; other antidepressants show limited efficacy and potential side effects like behavioral toxicity.

Conclusions:

• Multimodal interventions, including cognitive behavioral therapy and psychosocial support, are crucial for treating childhood and adolescent depression.
• Medication should be reserved for severe cases.
• Suicidal minors require specialized inpatient treatment in dedicated units.